Endurance exercise training improved brachial artery flow-mediated dilation in postmenopausal women treated with estradiol (P<0.025), but not in those receiving placebo (P=0.55).
RCT (n=36)
randomized
36 sedentary, estrogen-deficient postmenopausal women aged 45-65 years, randomized to placebo or estradiol for 12 weeks followed by 12 weeks of concurrent endurance exercise training.
Estradiol plus endurance exercise training vs Placebo plus endurance exercise training (oral (1 mg/d) or transdermal (0.05 mg/d))
Brachial artery flow-mediated dilation (FMD), p=<.025
valor p: p=<.025
OBJECTIVE: In contrast to age-matched men, endurance exercise training is not consistently associated with enhanced endothelial function in estrogen-deficient postmenopausal women. We determined whether endurance exercise training improves endothelial function in postmenopausal women treated with estrogen. In a substudy, we determined if oxidative stress is mechanistically linked to endothelial function adaptations to endurance exercise training. PARTICIPANTS AND DESIGN: Brachial artery flow-mediated dilation (FMD) was measured in 36 sedentary, estrogen-deficient postmenopausal women (45-65 y) at study entry (baseline), after 12 weeks of either placebo, oral (1 mg/d) estradiol, or transdermal estradiol (0.05 mg/d) (randomized), and after an additional 12 weeks of continued estradiol or placebo treatment with concurrent endurance exercise training. In subgroups of women, FMD also was measured during the infusion of ascorbic acid at baseline and following estradiol/placebo plus endurance exercise training, and in seven habitually endurance-trained estrogen-deficient controls. RESULTS: FMD increased in the estrogen-treated groups (both P < .01) after 12 weeks and remained unchanged in placebo. FMD further increased following 12 weeks of endurance exercise training in estrogen-treated (both P < .025), but not placebo-treated women (P = .55). In the substudy, baseline FMD was similar between sedentary and endurance-trained controls. Ascorbic acid increased FMD at baseline in sedentary women and endurance-trained controls, and following endurance exercise training in placebo-treated, but not in estrogen-treated women. CONCLUSIONS: Estrogen status appears to play an important modulatory role in improvements in endothelial function with endurance exercise training in postmenopausal women. The restored endurance exercise training adaptation in estrogen-treated postmenopausal women may be related to mitigation of oxidative stress.
Building similarity graph...
Analyzing shared references across papers
Loading...
Kerrie L. Moreau
Vascular Medicine
Brian L. Stauffer
Denver Health Medical Center
Wendy M. Kohrt
Northern Illinois University
The Journal of Clinical Endocrinology & Metabolism
University of Colorado Boulder
University of Colorado Denver
The Medical Center of Aurora
Building similarity graph...
Analyzing shared references across papers
Loading...
Moreau et al. (Fri,) conducted a rct in Estrogen deficiency in postmenopausal women (n=36). Estradiol plus endurance exercise training vs. Placebo plus endurance exercise training was evaluated on Brachial artery flow-mediated dilation (FMD) (p=<.025). Endurance exercise training improved brachial artery flow-mediated dilation in postmenopausal women treated with estradiol (P<0.025), but not in those receiving placebo (P=0.55).
synapsesocial.com/papers/6a225ef5ead6bb8ea577abe7 — DOI: https://doi.org/10.1210/jc.2013-2183
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: